SAB Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	10.5	8.9	56.57	15.05	39.55
Short-Term Investments	86.09	11.86	-	-	-
Cash & Short-Term Investments	96.59	20.76	56.57	15.05	39.55
Cash Growth	365.27%	-63.30%	275.93%	-61.95%	213.59%
Accounts Receivable	-	-	-	5.56	8.01
Other Receivables	0.95	0.05	-	-	-
Total Trade Receivables	0.95	0.05	-	5.56	8.01
Other Current Assets	3.51	2.98	2.34	1.49	2.64
Total Current Assets	101.05	23.79	58.91	22.1	50.19
Net Property, Plant & Equipment	19.4	19.92	24.68	28.34	30.95
Long-Term Investments	46.89	-	-	-	-
Other Long-Term Assets	5.46	0.48	0.35	0.47	-
Total Assets	172.81	44.2	83.94	50.9	81.14
Accounts Payable	3.15	1.69	0.95	3.68	4.46
Accrued Expenses	6.58	5.47	6.69	9.92	12.46
Short-Term Debt	-	0.28	1.05	0.77	-
Current Portion of Long-Term Debt	-	-	-	-	1.8
Current Portion of Leases	0.95	0.54	0.8	0.62	1.3
Unearned Revenue	-	-	1.32	-	0.1
Other Current Liabilities	-	-	-	-	6.34
Total Current Liabilities	10.68	7.98	10.81	14.99	26.46
Long-Term Debt	-	-	-	0.54	-
Long-Term Leases	5	3.86	4.05	3.99	1.65
Other Long-Term Liabilities	5.64	6.39	11.77	0.32	-
Total Long-Term Liabilities	10.63	10.25	15.83	4.85	1.65
Total Liabilities	21.32	18.23	26.64	19.85	28.11
Preferred Stock	0	0	0	-	-
Common Stock	0	0	0	0	-
Treasury Stock	-5.52	-5.52	-5.52	-5.52	-
Additional Paid-in Capital	267.72	155.79	152.86	84.45	-
Accumulated Other Comprehensive Income	0.19	-0.14	0.03	-	-
Retained Earnings	-110.9	-124.17	-90.06	-47.87	-
Shareholders' Equity	151.49	25.97	57.3	31.06	-
Total Liabilities & Equity	172.81	44.2	83.94	50.9	28.11
Total Debt	5.95	4.67	5.91	5.93	4.75
Net Cash (Debt)	90.64	16.09	50.66	9.12	34.79
Net Cash Growth	463.28%	-68.23%	455.59%	-73.79%	305.50%
Net Cash Per Share	1.48	1.74	9.18	2.10	12.73
Book Value	151.49	25.97	57.3	31.06	0
Book Value Per Share	2.47	2.80	10.38	7.14	-
Tangible Book Value	151.49	25.97	57.3	31.06	0
Tangible Book Value Per Share	2.47	2.80	10.38	7.14	-

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q